Non-competitive Fiscal Year 2017 Supplemental Funding Award Ryan White HIV/AIDS Program, Part F Special Projects of National Significance, 44815-44816 [2017-20541]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices
CFDA Number: 93.127.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Single-Award Deviations From
Competition Requirements: Pediatric
Emergency Care Applied Research
Network
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice of Single-Award
Deviation from Competition
Requirements for the Pediatric
Emergency Care Applied Research
Network (PECARN) at the Children’s
Hospital Medical Center, Cincinnati,
Ohio- Grant Number U03MC222684.
AGENCY:
HRSA announces the award
of a supplement of $50,000 for the
PECARN cooperative agreement. The
supplement will permit the Children’s
Hospital Medical Center, Cincinnati,
Ohio, the cooperative agreement
recipient to support its oversight of the
operation of PECARN as the Chair for
2017–2018.
SUPPLEMENTARY INFORMATION:
Intended Recipient of the Award:
Children’s Hospital Medical Center,
Cincinnati, Ohio.
Amount of Non-Competitive Awards:
$50,000.
Period of Supplemental Funding:
September 1, 2017, through August 31,
2018.
SUMMARY:
Authority: Public Health Service Act, Title
XIX, Section 1910 (42 U.S.C. 300w–9); as
amended by the Emergency Medical Services
for Children Reauthorization Act of 2014,
P.L. 113–180.
Justification: As stated in the funding
opportunity announcement, the goal of
the PECARN is to develop an efficient
research network to conduct high
quality research and publish evidencebased findings that will impact clinical
practice and ensure standardized care in
diverse health care settings that serve
children, including urban, rural, and
tribal settings. The objectives of this
award are to:
(1) Support a network infrastructure
to conduct high priority, high impact
EMSC research using rigorous study
designs and methodologies that can be
applied to multi-site Emergency
Department and/or prehospital
emergency settings;
(2) Contribute to an organizational
structure that ensures network
efficiency, productivity, and fidelity of
study implementation and includes the
ability to: (a) Develop study projects; (b)
Attain extramural funding; (c) Conduct
multi-site clinical investigations; (d)
Publish and disseminate results; and (e)
Develop young investigators in the area
of pediatric emergency medicine;
(3) Facilitate translation of research
results to EMSC practices; and
(4) Foster collaboration among EMS
personnel, nurses, practitioners, and
researchers.
Grantee/organization name
Grant No.
Children’s Hospital Medical Center ...................................................................
Dated: September 19, 2017.
George Sigounas,
Administrator.
ACTION:
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Non-competitive Fiscal Year 2017
Supplemental Funding Award Ryan
White HIV/AIDS Program, Part F
Special Projects of National
Significance
Health Resources and Services
Administration (HRSA), HHS.
AGENCY:
18:28 Sep 25, 2017
Notice.
This non-competitive
supplemental award to the University of
California, San Francisco (UCSF), the
Evaluation and Technical Assistance
Center (ETAC) for the Culturally
Appropriate Interventions of Outreach,
Access and Retention among Latino/a
Populations initiative, will support the
costs of analysis, publication, and
dissemination of findings and best
practices learned from the initiative.
SUPPLEMENTARY INFORMATION:
Intended Recipient of the Award:
UCSF (U90HA26507).
Amount of Non-Competitive Award:
$100,000.
Period of Funding: September 1, 2017,
through August 31, 2018.
CFDA Number: No. 93.928.
SUMMARY:
[FR Doc. 2017–20543 Filed 9–25–17; 8:45 am]
VerDate Sep<11>2014
U03MC222684
Jkt 241001
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
44815
Success of the PECARN requires the
services of a Chair, who is elected on an
annual basis by grantees. This annual
supplement is necessary to support the
Chair’s responsibilities which are
within the scope of the cooperative
agreement program, but were not
required to be budgeted for in the
organization’s application due to the
unknown contingency of who would be
elected as Chair on behalf of which
organization. Dr. Richard Ruddy of
Children’s Hospital Medical Center,
Cincinnati, Ohio, was elected Chair of
the PECARN for 2016–2018. The
proposed supplement is to supply funds
to the Chair to support his oversight of
the operation of PECARN including
coordinating and running the Steering
Committee meetings, appointing
Subcommittee Chairpersons to be later
approved by the Steering Committee;
maintaining ongoing communications
with principal investigators and keeping
all of PECARN updated with new/
ongoing activities; representing
PECARN at national meetings; and
serving as liaison to HRSA/Maternal
and Child Health Bureau federal
officials.
FOR FURTHER INFORMATION CONTACT:
Diane Pilkey, Division of Child,
Adolescent and Family Health, Maternal
and Child Health Bureau, Health
Resources and Services Administration,
5600 Fishers Lane, Room 18N58C,
Rockville, MD 20852, Phone: 301–443–
8927, Email: DPilkey@hrsa.gov.
State
OH
FY 2017
Authorized
funding level
$735,918
FY 2017
Estimated
supplemental
funding
$50,000
Authority: Public Health Service Act,
Section 2691 (42 U.S.C. 300ff-101), as
amended by the Ryan White HIV/AIDS
Treatment Extension Act of 2009 (Pub. L.
111–87).
Justification: UCSF is currently
conducting a multisite evaluation and
providing technical assistance to the ten
demonstration sites awarded under this
initiative. The sites implement
innovative interventions that identify
Latinos/as at high risk or living with
HIV in the United States, and improve
their access, timely entry, and retention
in quality HIV primary care. This
supplemental funding will cover the
costs of a special supplemental issue of
a top-tier HIV/AIDS journal containing
findings from the initiative, and support
additional staff to assist in the analysis,
publication, and dissemination of
E:\FR\FM\26SEN1.SGM
26SEN1
44816
Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices
findings, best practices, and lessons
learned. The supported activity includes
the production of the required
interventions manual for the initiative
documenting the ten intervention
models employed by the demonstration
sites in order to promote the future
replication of the interventions by Ryan
White HIV/AIDS Program recipients and
other health care providers. Not issuing
this award would severely reduce the
impact of this initiative by limiting the
analysis and dissemination of best
practices and lessons learned to HIV
providers serving these Latino/a
subpopulations. This would weaken
efforts to improve the health outcomes
for Latinos/as living with HIV in the
United States.
FOR FURTHER INFORMATION CONTACT: Mr.
Adan Cajina, Chief, Demonstration
Evaluation Branch, Office of Training
and Capacity Development, Division of
HIV Domestic Programs, HIV/AIDS
Bureau, HRSA, 5600 Fishers Lane,
09N108, Rockville, MD 20857, Phone:
(301) 443–3180, Email: acajina@
hrsa.gov.
Dated: September 19, 2017.
George Sigounas,
Administrator.
[FR Doc. 2017–20541 Filed 9–25–17; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
National Vaccine Injury Compensation
Program: List of Petitions Received
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
HRSA is publishing this
notice of petitions received under the
National Vaccine Injury Compensation
Program (the program), as required by
the Public Health Service (PHS) Act, as
amended. While the Secretary of HHS is
named as the respondent in all
proceedings brought by the filing of
petitions for compensation under the
Program, the United States Court of
Federal Claims is charged by statute
with responsibility for considering and
acting upon the petitions.
FOR FURTHER INFORMATION CONTACT: For
information about requirements for
filing petitions, and the Program in
general, contact Lisa L. Reyes, Acting
Clerk, United States Court of Federal
Claims, 717 Madison Place NW.,
Washington, DC 20005, (202) 357–6400.
SUMMARY:
VerDate Sep<11>2014
18:28 Sep 25, 2017
Jkt 241001
For information on HRSA’s role in the
Program, contact the Director, National
Vaccine Injury Compensation Program,
5600 Fishers Lane, Room 08N146B,
Rockville, MD 20857; (301) 443–6593,
or visit our Web site at: https://
www.hrsa.gov/vaccinecompensation/
index.html.
The
program provides a system of no-fault
compensation for certain individuals
who have been injured by specified
childhood vaccines. Subtitle 2 of Title
XXI of the PHS Act, 42 U.S.C. 300aa–
10 et seq., provides that those seeking
compensation are to file a petition with
the U.S. Court of Federal Claims and to
serve a copy of the petition on the
Secretary of HHS, who is named as the
respondent in each proceeding. The
Secretary has delegated this
responsibility under the Program to
HRSA. The Court is directed by statute
to appoint special masters who take
evidence, conduct hearings as
appropriate, and make initial decisions
as to eligibility for, and amount of,
compensation.
A petition may be filed with respect
to injuries, disabilities, illnesses,
conditions, and deaths resulting from
vaccines described in the Vaccine Injury
Table (the Table) set forth at 42 CFR
100.3. This Table lists for each covered
childhood vaccine the conditions that
may lead to compensation and, for each
condition, the time period for
occurrence of the first symptom or
manifestation of onset or of significant
aggravation after vaccine
administration. Compensation may also
be awarded for conditions not listed in
the Table and for conditions that are
manifested outside the time periods
specified in the Table, but only if the
petitioner shows that the condition was
caused by one of the listed vaccines.
Section 2112(b)(2) of the PHS Act, 42
U.S.C. 300aa–12(b)(2), requires that
‘‘[w]ithin 30 days after the Secretary
receives service of any petition filed
under section 2111 the Secretary shall
publish notice of such petition in the
Federal Register.’’ Set forth below is a
list of petitions received by HRSA on
August 1, 2017, through August 31,
2017. This list provides the name of
petitioner, city and state of vaccination
(if unknown then city and state of
person or attorney filing claim), and
case number. In cases where the Court
has redacted the name of a petitioner
and/or the case number, the list reflects
such redaction.
Section 2112(b)(2) also provides that
the special master ‘‘shall afford all
interested persons an opportunity to
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
submit relevant, written information’’
relating to the following:
1. The existence of evidence ‘‘that
there is not a preponderance of the
evidence that the illness, disability,
injury, condition, or death described in
the petition is due to factors unrelated
to the administration of the vaccine
described in the petition,’’ and
2. Any allegation in a petition that the
petitioner either:
a. ‘‘[S]ustained, or had significantly
aggravated, any illness, disability,
injury, or condition not set forth in the
Vaccine Injury Table but which was
caused by’’ one of the vaccines referred
to in the Table, or
b. ‘‘[S]ustained, or had significantly
aggravated, any illness, disability,
injury, or condition set forth in the
Vaccine Injury Table the first symptom
or manifestation of the onset or
significant aggravation of which did not
occur within the time period set forth in
the Table but which was caused by a
vaccine’’ referred to in the Table.
In accordance with Section
2112(b)(2), all interested persons may
submit written information relevant to
the issues described above in the case of
the petitions listed below. Any person
choosing to do so should file an original
and three (3) copies of the information
with the Clerk of the U.S. Court of
Federal Claims at the address listed
above (under the heading FOR FURTHER
INFORMATION CONTACT), with a copy to
HRSA addressed to Director, Division of
Injury Compensation Programs,
Healthcare Systems Bureau, 5600
Fishers Lane, 08N146B, Rockville, MD
20857. The Court’s caption (Petitioner’s
Name v. Secretary of HHS) and the
docket number assigned to the petition
should be used as the caption for the
written submission. Chapter 35 of title
44, United States Code, related to
paperwork reduction, does not apply to
information required for purposes of
carrying out the program.
Dated: September 19, 2017
George Sigounas,
Administrator.
List of Petitions Filed
1. Teresa Audino and David Audino on
behalf of C. A., Vienna, Virginia
Court of Federal Claims No: 17–1033V
2. Stephanie C. Savage, Greensboro,
North Carolina
Court of Federal Claims No: 17–1036V
3. Alfred Wade, Jr. on behalf of Elaine
D. Wade, Deceased, Wilmington,
North Carolina
Court of Federal Claims No: 17–1039V
4. Tiffany S. Gaiter and Deverett S.
Gaiter on behalf of Deverett S. Jr.
Gaiter, Bay City, Michigan
E:\FR\FM\26SEN1.SGM
26SEN1
]]>Agencies
[Federal Register Volume 82, Number 185 (Tuesday, September 26, 2017)]
[Notices]
[Pages 44815-44816]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20541]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Non-competitive Fiscal Year 2017 Supplemental Funding Award Ryan
White HIV/AIDS Program, Part F Special Projects of National
Significance
AGENCY: Health Resources and Services Administration (HRSA), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This non-competitive supplemental award to the University of
California, San Francisco (UCSF), the Evaluation and Technical
Assistance Center (ETAC) for the Culturally Appropriate Interventions
of Outreach, Access and Retention among Latino/a Populations
initiative, will support the costs of analysis, publication, and
dissemination of findings and best practices learned from the
initiative.
SUPPLEMENTARY INFORMATION:
Intended Recipient of the Award: UCSF (U90HA26507).
Amount of Non-Competitive Award: $100,000.
Period of Funding: September 1, 2017, through August 31, 2018.
CFDA Number: No. 93.928.
Authority: Public Health Service Act, Section 2691 (42 U.S.C.
300ff-101), as amended by the Ryan White HIV/AIDS Treatment
Extension Act of 2009 (Pub. L. 111-87).
Justification: UCSF is currently conducting a multisite evaluation
and providing technical assistance to the ten demonstration sites
awarded under this initiative. The sites implement innovative
interventions that identify Latinos/as at high risk or living with HIV
in the United States, and improve their access, timely entry, and
retention in quality HIV primary care. This supplemental funding will
cover the costs of a special supplemental issue of a top-tier HIV/AIDS
journal containing findings from the initiative, and support additional
staff to assist in the analysis, publication, and dissemination of
[[Page 44816]]
findings, best practices, and lessons learned. The supported activity
includes the production of the required interventions manual for the
initiative documenting the ten intervention models employed by the
demonstration sites in order to promote the future replication of the
interventions by Ryan White HIV/AIDS Program recipients and other
health care providers. Not issuing this award would severely reduce the
impact of this initiative by limiting the analysis and dissemination of
best practices and lessons learned to HIV providers serving these
Latino/a subpopulations. This would weaken efforts to improve the
health outcomes for Latinos/as living with HIV in the United States.
FOR FURTHER INFORMATION CONTACT: Mr. Adan Cajina, Chief, Demonstration
Evaluation Branch, Office of Training and Capacity Development,
Division of HIV Domestic Programs, HIV/AIDS Bureau, HRSA, 5600 Fishers
Lane, 09N108, Rockville, MD 20857, Phone: (301) 443-3180, Email:
acajina@hrsa.gov.
Dated: September 19, 2017.
George Sigounas,
Administrator.
[FR Doc. 2017-20541 Filed 9-25-17; 8:45 am]
BILLING CODE 4165-15-P
